PAPER Sojkova J, Resnick SM
SEARCH RESULTS
329930 RESULTS
PAPER Driscoll I, Troncoso J
Asymptomatic Alzheimer's disease: a prodrome or a state of resilience?
Curr Alzheimer Res. 2011 Jun;8(4):330-5. PubMed: 21222594PAPER Beason-Held LL
Dementia and the default mode.
Curr Alzheimer Res. 2011 Jun;8(4):361-5. PubMed: 21222595PAPER Rohrer JD, Schott JM
Primary progressive aphasia: defining genetic and pathological subtypes.
Curr Alzheimer Res. 2011 May 1;8(3):266-72. PubMed: 21222598PAPER Williamson R, Sutherland C
Neuronal membranes are key to the pathogenesis of Alzheimer's disease: the role of both raft and non-raft membrane domains.
Curr Alzheimer Res. 2011 Mar;8(2):213-21. PubMed: 21222605PAPER Kandimalla RJ, Prabhakar S, Binukumar BK, Wani WY, Gupta N, Sharma DR, Sunkaria A, Grover VK, Bhardwaj N, Jain K, Gill KD
Apo-Eε4 allele in conjunction with Aβ42 and tau in CSF: biomarker for Alzheimer's disease.
Curr Alzheimer Res. 2011 Mar;8(2):187-96. PubMed: 21222606PAPER Kavanagh S, Howe I, Brashear HR, Wang D, Van Baelen B, Todd M, Schwalen S
Long-term response to galantamine in relation to short-term efficacy data: pooled analysis in patients with mild to moderate Alzheimer's disease.
Curr Alzheimer Res. 2011 Mar;8(2):175-86. PubMed: 21222607PAPER Sieradzki A, Yendluri BB, Palacios HH, Parvathaneni K, Reddy VP, Obrenovich ME, Gąsiorowski K, Leszek J, Aliev G
Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders- contemporary approaches.
CNS Neurol Disord Drug Targets. 2011 Mar;10(2):175-83. PubMed: 21222633PAPER Simon D, Medina M, Avila J, Wandosell F
Overcoming cell death and tau phosphorylation mediated by PI3K-inhibition: a cell assay to measure neuroprotection.
CNS Neurol Disord Drug Targets. 2011 Mar;10(2):208-14. PubMed: 21222634PAPER Wang C
Solution NMR studies of Aβ monomer dynamics.
Protein Pept Lett. 2011 Apr;18(4):354-61. PubMed: 21222639PAPER Galimberti D, Scarpini E
Alzheimer's disease: from pathogenesis to disease-modifying approaches.
CNS Neurol Disord Drug Targets. 2011 Mar;10(2):163-74. PubMed: 21222635PAPER Son J, Song S, Lee S, Chang S, Kim M
Morphological change tracking of dendritic spines based on structural features.
J Microsc. 2011 Mar;241(3):261-72. PubMed: 21223260PAPER Liem-Moolenaar M, Rad M, Zamuner S, Cohen AF, Lemme F, Franson KL, van Gerven JM, Pich EM
Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men.
Br J Clin Pharmacol. 2011 Jun;71(6):907-16. PubMed: 21223356PAPER Leung KK, Finlay J, Silvius JL, Koehn S, McCleary L, Cohen CA, Hum S, Garcia L, Dalziel W, Emerson VF, Pimlott NJ, Persaud M, Kozak J, Drummond N
Pathways to diagnosis: exploring the experiences of problem recognition and obtaining a dementia diagnosis among Anglo-Canadians.
Health Soc Care Community. 2011 Jul;19(4):372-81. PubMed: 21223398PAPER Muramatsu H, Yokoi K, Chen L, Ichihara-Tanaka K, Kimura T, Muramatsu T
Midkine as a factor to counteract the deposition of amyloid β-peptide plaques: in vitro analysis and examination in knockout mice.
Int Arch Med. 2011;4(1):1. PubMed: 21223602Current Filters
No filters selected